Details for Patent: 8,968,753
✉ Email this page to a colleague
Which drugs does patent 8,968,753 protect, and when does it expire?
Patent 8,968,753 protects ZERBAXA and is included in one NDA.
This patent has thirty-three patent family members in eighteen countries.
Summary for Patent: 8,968,753
Title: | Ceftolozane-tazobactam pharmaceutical compositions |
Abstract: | Pharmaceutical compositions can include ceftolozane lyophilized in the absence of tazobactam. |
Inventor(s): | Terracciano; Joseph (Concord, MA), Damour; Nicole Miller (Belmont, MA), Jiang; Chun (Hillsborough, CA), Fogliato; Giovanni (Barzana, IT), Donadelli; Giuseppe Alessandro (Casalpusterlengo, IT), Resemini; Dario (Milan, IT) |
Assignee: | Calixa Therapeutics, Inc. (Lexington, MA) |
Application Number: | 14/285,185 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Process; |
Drugs Protected by US Patent 8,968,753
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cubist Pharms Llc | ZERBAXA | ceftolozane sulfate; tazobactam sodium | POWDER;INTRAVENOUS | 206829-001 | Dec 19, 2014 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF COMPLICATED URINARY TRACT INFECTION, INCLUDING PYELONEPHRITIS | ⤷ Try a Trial | ||||
Cubist Pharms Llc | ZERBAXA | ceftolozane sulfate; tazobactam sodium | POWDER;INTRAVENOUS | 206829-001 | Dec 19, 2014 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTION | ⤷ Try a Trial | ||||
Cubist Pharms Llc | ZERBAXA | ceftolozane sulfate; tazobactam sodium | POWDER;INTRAVENOUS | 206829-001 | Dec 19, 2014 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | COMPLICATED URINARY TRACT INFECTIONS (CUTI), INCLUDING PYELONEPHRITIS, IN ADULT AND PEDIATRIC PATIENTS (BIRTH TO LESS THAN 18 YEARS OLD) | ⤷ Try a Trial | ||||
Cubist Pharms Llc | ZERBAXA | ceftolozane sulfate; tazobactam sodium | POWDER;INTRAVENOUS | 206829-001 | Dec 19, 2014 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | COMPLICATED INTRA-ABDOMINAL INFECTIONS (CIAI), USED IN COMBINATION WITH METRONIDAZOLE, IN ADULT AND PEDIATRIC PATIENTS (BIRTH TO LESS THAN 18 YEARS OF AGE) | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,968,753
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2014227660 | ⤷ Try a Trial | |||
Australia | 2015200599 | ⤷ Try a Trial | |||
Brazil | 112015023523 | ⤷ Try a Trial | |||
Canada | 2906151 | ⤷ Try a Trial | |||
Chile | 2015002755 | ⤷ Try a Trial | |||
China | 105392485 | ⤷ Try a Trial | |||
China | 110279698 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |